For Immediate Release
Chicago, IL – July 16, 2026 – Stocks in this week’s article are NVIDIA Corp. NVDA, Neurocrine Biosciences, Inc. NBIX and Ball Corp. BALL.
NVIDIA & 2 Best Earnings Growth Stocks to Buy for 2H 2026
Earnings growth is essential for organizations of all sizes because sustained profitability is key to survival. To calculate earnings, examine a company's revenues over a certain period and subtract the production costs. A company's earnings have a significant influence on its share price, with earnings expectations playing a key role in determining market performance.
Against this backdrop, NVIDIA Corp., Neurocrine Biosciences, Inc. and Ball Corp. are delivering strong and impressive earnings growth, making them compelling investment opportunities for the second half of this year.
Earnings Estimates & Share Price Movements
We have frequently seen stock prices decline despite earnings growth or rally after an earnings decline. This is largely the result of a company's earnings failing to meet market expectations.
Earnings estimates reflect analysts' views on factors such as sales growth, product demand, the competitive industry environment, profit margins, and cost control. Consequently, earnings estimates are a valuable tool for making investment decisions. They also help analysts evaluate cash flow to determine a firm's fair value.
Thus, investors should be on the lookout for stocks ready to make a big move. Such stocks should have a history of earnings growth and rising quarterly and annual earnings estimates.
The above criteria narrowed the universe of around 7,839 stocks to only 24. Here are the top three stocks:
NVIDIA
NVIDIA is a leading AI infrastructure company with operations across the United States, Taiwan, China, Hong Kong, Europe and other global markets. The company's expected earnings growth rate for the current year is 90.8%. NVDA currently has a Zacks Rank #2 (Buy) (read more: Missed NVIDIA's 900% Run? Micron Could Be AI's Next Big Winner).
Neurocrine Biosciences
Neurocrine Biosciences is a biopharmaceutical company focused on developing treatments for neurological, neuroendocrine and psychiatric disorders. The company's expected earnings growth rate for the current year is 48.4%. NBIX currently has a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
Ball
Ball supplies aluminum packaging solutions for the beverage, personal care and household products industries worldwide. The company's expected earnings growth rate for the current year is 11.8%. BALL currently has a Zacks Rank #2.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2954310/nvidia-2-best-earnings-growth-stocks-to-buy-for-2h-2026
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NVIDIA Corporation (NVDA): Free Stock Analysis Report
Neurocrine Biosciences, Inc. (NBIX): Free Stock Analysis Report
Ball Corporation (BALL): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).